Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytodiagnosis | 4 | 2018 | 220 | 1.180 |
Why?
|
| DNA Mutational Analysis | 5 | 2018 | 2283 | 0.920 |
Why?
|
| Biopsy, Fine-Needle | 6 | 2018 | 690 | 0.770 |
Why?
|
| Pathology, Molecular | 1 | 2021 | 128 | 0.740 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2018 | 2291 | 0.700 |
Why?
|
| Specimen Handling | 2 | 2018 | 299 | 0.690 |
Why?
|
| Pleural Effusion, Malignant | 2 | 2012 | 156 | 0.570 |
Why?
|
| Laser Capture Microdissection | 2 | 2012 | 43 | 0.550 |
Why?
|
| Cushing Syndrome | 1 | 2014 | 70 | 0.480 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 1910 | 0.420 |
Why?
|
| Papillomaviridae | 1 | 2014 | 624 | 0.390 |
Why?
|
| Thymoma | 1 | 2014 | 246 | 0.390 |
Why?
|
| Precision Medicine | 1 | 2018 | 1154 | 0.380 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 7548 | 0.360 |
Why?
|
| Thymus Neoplasms | 1 | 2014 | 400 | 0.350 |
Why?
|
| Lung Neoplasms | 5 | 2021 | 11538 | 0.330 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2014 | 716 | 0.320 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 2483 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-met | 3 | 2014 | 419 | 0.290 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 3578 | 0.290 |
Why?
|
| Breast Neoplasms | 3 | 2022 | 15694 | 0.280 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 980 | 0.280 |
Why?
|
| Neoplasms | 6 | 2018 | 15193 | 0.270 |
Why?
|
| Adenocarcinoma | 5 | 2015 | 7789 | 0.270 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2006 | 93 | 0.270 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2006 | 129 | 0.260 |
Why?
|
| T-Box Domain Proteins | 1 | 2006 | 156 | 0.260 |
Why?
|
| Biomarkers, Tumor | 6 | 2021 | 10331 | 0.260 |
Why?
|
| Caenorhabditis elegans | 1 | 2006 | 268 | 0.240 |
Why?
|
| Receptor, ErbB-2 | 3 | 2022 | 2518 | 0.230 |
Why?
|
| Gene Amplification | 3 | 2014 | 731 | 0.220 |
Why?
|
| Melanoma-Specific Antigens | 1 | 2013 | 82 | 0.220 |
Why?
|
| S100 Proteins | 1 | 2013 | 181 | 0.220 |
Why?
|
| Pathologists | 1 | 2021 | 91 | 0.190 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 3976 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 5437 | 0.160 |
Why?
|
| Centrifugation | 1 | 2018 | 66 | 0.160 |
Why?
|
| Mutation | 7 | 2015 | 15179 | 0.160 |
Why?
|
| Humans | 21 | 2022 | 261506 | 0.140 |
Why?
|
| Tissue Embedding | 1 | 2015 | 28 | 0.130 |
Why?
|
| Sampling Studies | 1 | 2015 | 170 | 0.130 |
Why?
|
| Human Papillomavirus DNA Tests | 1 | 2014 | 18 | 0.130 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2014 | 156 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2007 | 837 | 0.120 |
Why?
|
| Urogenital Neoplasms | 1 | 2014 | 108 | 0.110 |
Why?
|
| F-Box Proteins | 1 | 2014 | 96 | 0.110 |
Why?
|
| Hematoxylin | 1 | 2012 | 34 | 0.110 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 2012 | 52 | 0.110 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2012 | 44 | 0.110 |
Why?
|
| Automation | 1 | 2012 | 151 | 0.110 |
Why?
|
| Prognosis | 6 | 2015 | 21713 | 0.110 |
Why?
|
| DNA, Viral | 1 | 2014 | 694 | 0.110 |
Why?
|
| Gastrectomy | 1 | 2015 | 451 | 0.100 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 1363 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 1165 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 4744 | 0.090 |
Why?
|
| Carcinoma, Lobular | 1 | 2014 | 611 | 0.090 |
Why?
|
| Genomics | 1 | 2021 | 2738 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 4367 | 0.090 |
Why?
|
| Receptors, Progesterone | 1 | 2015 | 1392 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 4971 | 0.090 |
Why?
|
| Lung Diseases, Fungal | 1 | 2010 | 124 | 0.080 |
Why?
|
| Female | 11 | 2022 | 141928 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 5159 | 0.080 |
Why?
|
| Proteins | 1 | 2007 | 1963 | 0.080 |
Why?
|
| Amphotericin B | 1 | 2010 | 289 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 4892 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 854 | 0.080 |
Why?
|
| Mucormycosis | 1 | 2010 | 108 | 0.080 |
Why?
|
| Peritoneal Neoplasms | 1 | 2015 | 821 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2015 | 2218 | 0.080 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 2086 | 0.080 |
Why?
|
| Pleural Effusion | 1 | 2010 | 201 | 0.080 |
Why?
|
| ras Proteins | 1 | 2011 | 770 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 1216 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 1546 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 4638 | 0.070 |
Why?
|
| Embryonic Induction | 1 | 2006 | 54 | 0.070 |
Why?
|
| Blastomeres | 1 | 2006 | 24 | 0.070 |
Why?
|
| Pharyngeal Muscles | 1 | 2006 | 36 | 0.070 |
Why?
|
| Melanoma | 1 | 2013 | 5317 | 0.070 |
Why?
|
| Male | 8 | 2015 | 123000 | 0.070 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 4844 | 0.070 |
Why?
|
| Adult | 7 | 2015 | 77950 | 0.060 |
Why?
|
| DNA | 1 | 2013 | 2693 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 2045 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2014 | 2967 | 0.060 |
Why?
|
| Antifungal Agents | 1 | 2010 | 834 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2006 | 668 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2011 | 2295 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 2488 | 0.050 |
Why?
|
| Phenotype | 1 | 2014 | 6295 | 0.050 |
Why?
|
| Young Adult | 3 | 2015 | 21445 | 0.050 |
Why?
|
| Stomach Neoplasms | 1 | 2015 | 2278 | 0.050 |
Why?
|
| Aged | 7 | 2015 | 70117 | 0.050 |
Why?
|
| Middle Aged | 8 | 2015 | 86204 | 0.050 |
Why?
|
| Binding Sites | 1 | 2006 | 2171 | 0.050 |
Why?
|
| Clinical Trials, Phase I as Topic | 2 | 2014 | 604 | 0.050 |
Why?
|
| Esophageal Neoplasms | 1 | 2015 | 3168 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 3343 | 0.050 |
Why?
|
| Risk Factors | 2 | 2015 | 17523 | 0.050 |
Why?
|
| Epithelium | 1 | 2012 | 720 | 0.050 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 1742 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 2216 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 5319 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 4757 | 0.040 |
Why?
|
| Neoplasm Staging | 4 | 2015 | 13658 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2012 | 5270 | 0.040 |
Why?
|
| Cattle | 1 | 2007 | 783 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 997 | 0.030 |
Why?
|
| Dogs | 1 | 2007 | 1155 | 0.030 |
Why?
|
| DNA Primers | 1 | 2007 | 1399 | 0.030 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2014 | 83 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 5112 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2013 | 6100 | 0.030 |
Why?
|
| Texas | 2 | 2014 | 6311 | 0.030 |
Why?
|
| Maryland | 1 | 2011 | 48 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2014 | 9180 | 0.030 |
Why?
|
| Esophagogastric Junction | 1 | 2015 | 543 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 14289 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12221 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 280 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 4233 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 3639 | 0.020 |
Why?
|
| Base Sequence | 1 | 2007 | 4917 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 3101 | 0.020 |
Why?
|
| Empyema, Pleural | 1 | 2010 | 48 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 6089 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 14889 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 2232 | 0.020 |
Why?
|
| Liposomes | 1 | 2010 | 684 | 0.020 |
Why?
|
| Animals | 2 | 2007 | 59536 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 3203 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 2508 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 2292 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1516 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1331 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 3260 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2330 | 0.020 |
Why?
|
| Adolescent | 2 | 2014 | 31252 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 29902 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2014 | 32848 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 6009 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 12926 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 16273 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 34495 | 0.010 |
Why?
|
| Child | 1 | 2014 | 29154 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 37905 | 0.010 |
Why?
|